A randomized controlled trial of cetirizine plus pseudoephedrine versus loratadine plus pseudoephedrine for perennial allergic rhinitis

Asian Pacific Journal of Allergy and Immunology

Volumn 24, Issue 2-3, 2006, Pages 97-103

  Chiang, Yi Chi ^a,b   Shyur, Shyh Dar ^a   Chen, Tien Ling ^a   Huang, Li Hsin ^a   Wen, Ta Chzng ^a   Lin, Mao Tsair ^a   Yang, Hwai Chih ^a   Liang, Pei Hsuan ^a   Kao, Yu Hsuan ^a   Wang, Tsung Chi ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; LORATADINE; PLACEBO; PSEUDOEPHEDRINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HEART PALPITATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NASAL PRURITUS; NOSE CONGESTION; OUTCOME ASSESSMENT; PARALLEL DESIGN; PERENNIAL RHINITIS; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINORRHEA; SCHOOL CHILD; SIDE EFFECT; SNEEZING; SYMPTOM; TAIWAN; THIRST; TREATMENT DURATION; WEAKNESS;

ADOLESCENT; ADULT; AGED; CETIRIZINE; CHILD; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPHEDRINE; FEMALE; HUMANS; LORATADINE; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; SNEEZING; TAIWAN; TREATMENT OUTCOME;

EID: 33751001023     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Fornadley JA, Corey JP, Osguthorpe JD, et al. Allergic rhinitis: clinical practice guideline. Committee on Practice Standards, American Academy of Otolaryngic Allergy. Otolaryngol Head Neck Surg 1996; 115: 115-22.
2. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351: 1225-32.
3. Aberg N, Sundell J, Eriksson B, Hesselmar B, Aberg B. Prevalence of allergic diseases in schoolchildren in relation to family history, upper respiratory infections, and residential characteristics. Allergy 1996; 51: 232-7.
4. Sly RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999; 82: 233-48; quiz 248-52.
5. Li LF, Lin MC, Yang CT, et al. Comparison of indoor allergens, allergic scores, and demographic data in Taiwanese adults with asthma or allergic rhinitis, or both. J Formos Med Assoc 1999; 98: 486-91.
6. Wang WC, Lue KH, Sheu JN. Allergic diseases in preschool children in Taichung City. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1998; 39: 314-8.
7. Hsieh KH, Shen JJ. Prevalence of childhood asthma in Taipei, Taiwan, and other Asian Pacific countries. J Asthma 1988; 25: 73-82.
8. Simons FE. Learning impairment and allergic rhinitis. Allergy Asthma Proc 1996; 17: 185-9.
9. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994; 94: 182-8.
10. Cockburn IM, Bailit HL, Berndt ER, Finkelstein SN. Loss of work productivity due to illness and medical treatment. J Occup Environ Med 1999; 41: 948-53.
11. Bousquet J. Antihistamines in severe/chronic rhinitis. Clin Exp Allergy 1998; 28 Suppl 6: 49-53.
12. Haria M, Fitton A, Peters DH. Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 1994; 48: 617-7.
13. Sheffer AL, Samuels LL. Cetirizine: anti-allergic therapy beyond traditional H1 antihistamines. J Allergy Clin Immunol 1990; 86: 1040-6.
14. Herman D, Arnaud A, Dry J, et al. Clinical effectiveness and tolerance of loratadine versus cetirizine in the treatment of seasonal allergic rhinitis. Allerg Immunol (Paris) 1992; 24: 270-4.
15. Snowman AM, Snyder SH. Cetirizine: actions on neurotransmitter receptors. J Allergy Clin Immunol 1990; 86: 1025-8.
16. Spencer CM, Faulds D, Peters DH. Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993; 46: 1055-80.
17. Curran MP, Scott LJ, Perry CM. Cetirizine: a review of its use in allergic disorders. Drugs 2004; 64: 523-61.
18. Tarnasky PR, Van Arsdel PP, Jr. Antihistamine therapy in allergic rhinitis. J Fam Pract 1990; 30: 71-80.
19. Simons FE. Non-cardiac adverse effects of antihistamines (H1-receptor antagonists). Clin Exp Allergy 1999; 29 Supp 1 3: 125-32.
20. Hamilton LH, Chobanian SL, Cato A, Perkins JG. A study of sustained action pseudoephedrine in allergic rhinitis. Ann Allergy 1982; 48: 87-92.
21. Bertrand B, Jamart J, Marchal JL, Arendt C. Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial allergic rhinitis: a double-blind multicentre study. Rhinology 1996; 34: 91-6.
22. Grosclaude M, Mees K, Pinelli ME, Lucas M, Van de Venne H. Cetirizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis. Rhinology 1997; 35: 67-73.
23. Bronsky E, Boggs P, Findlay S, et al. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol 1995; 96: 139-47.
24. Meltzer EO, Weiler JM, Widlitz MD. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97: 617-26.
25. Day JH, Briscoe M, Rafeiro E, Chapman D, Kramer B. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system. Ann Allergy Asthma Immunol 2001; 87: 474-81.
26. Sienra-Monge JJ, Gazca-Aguilar A, Del Rio-Navarro B. Double-blind comparison of cetirizine and loratadine in children ages 2 to 6 years with perennial allergic rhinitis. Am J Ther 1999; 6: 149-55.
27. Day JH, Briscoe MP, Clark RH, Ellis AK, Gervais P. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis. Ann Allergy Asthma Immunol 1997; 79: 163-72.
28. Nunes C, Ladeira S. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis. J Investig Allergol Clin Immunol 2000; 10: 20-3.
29. Tarchalska-Krynska B, Zawisza E. Test for efficacy of cetirizine and loratadine as a treatment for seasonal allergic rhinitis in a 6 week cross-over comparative study. Pneumonol Allergol Pol 1994; 62: 573-7.
30. Georgitis JW, Meltzer EO, Kaliner M, Weiler J, Berkowitz R. Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge. Ann Allergy Asthma Immunol 2000; 84: 451-9.
31. Corren J, Harris AG, Aaronson D, et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997; 100: 781-8.